Vascular inflammation and metabolic activity in hematopoietic organs and liver in familial combined hyperlipidemia and heterozygous familial hypercholesterolemia
BACKGROUND: Familial dyslipidemias of either heterozygous (heFH) or combined (FCH) type lead to accelerated atherogenesis and increased cardiovascular risk.
OBJECTIVE: The aim of this study was to investigate in statin-naïve adult patients with familial dyslipidemias whether inflammatory activation and liver, spleen and bone marrow metabolic activity differ compared with normolipidemic subjects and between dyslipidemic groups.
- Publication status:
- Peer review status:
- Peer reviewed
(Accepted manuscript, pdf, 1.3MB)
- Publisher copy:
- Copyright holder:
- National Lipid Association
- Copyright date:
- © 2017 National Lipid Association. All rights reserved. This is the Accepted Manuscript version of the article. The final version is available online from Elsevier at: https://doi.org/10.1016/j.jacl.2017.10.019
If you are the owner of this record, you can report an update to it here: Report update to this record